简体中文 | 繁體中文 | English

Products & Services News

2021-01-26 18:15 UAEREP Launches Fourth Cycle and Starts Receiving Project Proposals
2021-01-26 16:33 Velodyne Lidar LIVE! Webinar Series Explores Autonomy in Smarter Cities, Caves, Airports and Disaster Response
2021-01-26 15:08 Health Professionals Petition WHO for Guidance: People Should Use Nasal Sprays to Combat COVID-19 Pandemic; Doctors Use in Treating Patients
2021-01-26 14:45 Alaska Cargo and Cold Storage Launches Major Addition to the Global Cold Chain
2021-01-26 13:02 “Look for the WELL Health-Safety Seal” Public Awareness Campaign Launches, Featuring Lady Gaga, Jennifer Lopez, Michael B. Jordan, Robert DeNiro, Venus Williams, Wolfgang Puck, Deepak Chopra and 17th U.S. Surgeon General Richard Carmona
2021-01-25 18:07 BioBytes™ – Redefining How We Care for Our Health One Byte at a Time
2021-01-25 14:26 JEOL: Release of a New Cold Field Emission Cryo-Electron Microscope CRYO ARM™ 300 II (JEM-3300)
2021-01-25 14:00 Mitsui Mining & Smelting Co., Ltd. to Initiate Mass Production of HRDP®, a Special Glass Carrier for Next-Generation Semiconductor Packaging Devices
2021-01-22 18:42 GTJAI to Boost VSPN’s Innovation and Development
2021-01-22 16:19 Andersen Global Strengthens African Platform with Kashadah & Co.
2021-01-22 10:22 Everbridge Unveils Next-Generation Front-End Alerting Interface for Industry-Leading Global Public Warning Platform
2021-01-22 10:20 ViiV Healthcare announces FDA approval of Cabenuva (cabotegravir, rilpivirine), the first and only complete long-acting regimen for HIV treatment
2021-01-22 10:15 Tinubu® Square Announces Technological Collaboration With Microsoft
2021-01-21 18:21 CYNORA Announces Availability of Industry’s First Device Test Kits for TADF Deep Green Emitters for Next-Generation OLED Displays
2021-01-21 18:19 SmartStream Reveal Their Latest API Suite With a Complete Range of Reference Data Services
2021-01-21 18:17 Bel Power Solutions and Transphorm Announce Family of Titanium Efficiency AC to DC Power Supplies
2021-01-21 13:10 Aptorum Group Receives Clearance from Health Canada to Initiate a Phase 1 Clinical Trial for ALS-4, a Small Molecule Drug for Infections Caused by Staphylococcus aureus including Methicillin-resistant Staphylococcus aureus (MRSA)
2021-01-21 10:00 Boyd Corporation Expands Global Footprint With State of the Art Facility in Mexico
2021-01-20 18:07 Velodyne Lidar and Trunk.Tech Announce Strategic Partnership in Autonomous Trucking
2021-01-20 18:05 Andersen Global Enters Malawi